Teva’s Rx For GDUFA III: Treat Complex Generics More Like NDAs

 
• By Sue Sutter
Silhouette of diving board at sunset
FDA and industry want to use the successes of GDUFA II as a springboard to a new generic drug user fee agreement. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics